Edgar Filing: Xylem Inc.

Large accelerated filer

Accelerated filer

Non-accelerated filer

þ (Do not check if a smaller reporting company)

Smaller reporting company

FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2012

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 1-35229

Xylem Inc.

(Exact name of registrant as specified in its charter)

Indiana

45-2080495

(State or other jurisdiction of incorporation or

organization)

(I.R.S. Employer Identification No.)

1133 Westchester Avenue, Suite N200, White Plains, NY 10604

(Address of principal executive offices) (Zip Code)

(914) 323-5700

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No þ

As of July 31, 2012, there were 185,593,824 outstanding shares of the registrant’s common stock, par value $0.01 per share.

Xylem Inc.

Table of Contents


ITEM			PAGE
PART I – Financial Information

Item 1	–	Condensed Consolidated and Combined Financial Statements:

		Condensed Consolidated and Combined Income Statements for the Three Months and Six Months Ended June 30, 2012 and 2011 (Unaudited)		3

		Condensed Consolidated and Combined Statements of Comprehensive Income for the Three Months and Six Months Ended June 30, 2012 and 2011 (Unaudited)		4

		Condensed Consolidated Balance Sheets as of June 30, 2012 (Unaudited) and December 31, 2011		5

		Condensed Consolidated and Combined Statements of Cash Flows for the Six Months Ended June 30, 2012 and 2011 (Unaudited)		6

		Notes to the Condensed Consolidated and Combined Financial Statements (Unaudited)		7

Item 2	–	Management’s Discussion and Analysis of Financial Condition and Results of Operations		25

Item 3	–	Quantitative and Qualitative Disclosures About Market Risk		38

Item 4	–	Controls and Procedures		38

PART II – Other Information

Item 1	–	Legal Proceedings		39

Item 1A	–	Risk Factors		39

Item 2	–	Unregistered Sales of Equity Securities and Use of Proceeds		39

Item 3	–	Defaults Upon Senior Securities		39

Item 4	–	Mine Safety Disclosure		39

Item 5	–	Other Information		39

Item 6	–	Exhibits		39

Signatures				40

PART I

ITEM 1. CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED AND COMBINED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)


	Three Months					Six Months
For the periods ended June 30,	2012			2011		2012			2011
Revenue	$	966		$	971	$	1,891		$	1,861
Cost of revenue		583			592		1,145			1,145

Gross profit		383			379		746			716
Selling, general and administrative expenses		220			219		451			429
Research and development expenses		28			26		56			50
Separation costs		6			18		11			21

Operating income		129			116		228			216
Interest expense		13			1		27			1
Other non-operating (expense) income, net		(1	)		—		(2	)		1

Income before taxes		115			115		199			216
Income tax expense		26			43		47			66

Net income	$	89		$	72	$	152		$	150

Earnings per share:
Basic	$	0.48		$	0.39	$	0.82		$	0.82
Diluted	$	0.48		$	0.39	$	0.82		$	0.82
Weighted average number of shares:
Basic		185.8			184.6		185.6			184.6
Diluted		186.2			184.6		186.1			184.6
Dividends declared per share	$	0.1012		$	—	$	0.2024		$	—

See accompanying notes to condensed consolidated and combined financial statements.

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)

(in millions)


	Three Months					Six Months
For the periods ended June 30,	2012			2011		2012			2011
Net income	$	89		$	72	$	152		$	150
Other comprehensive income, before tax:
Foreign currency translation adjustment		(70	)		54		(21	)		140
Net change in cash flow hedges:
Unrealized gains (losses)		(2	)		—		2			—
Amount of loss reclassified into net income		(1	)		—		(1	)		—
Net change in postretirement benefit plans:
Amortization of net actuarial loss		3			1		5			1
Settlement		—			—		2			—

Other comprehensive (loss) income, before tax		(70	)		55		(13	)		141
Income tax expense related to items of other comprehensive income		1			—		3			—

Other comprehensive income, net of tax		(71	)		55		(16	)		141

Comprehensive income	$	18		$	127	$	136		$	291

See accompanying notes to condensed consolidated and combined financial statements.

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except per share amounts)


	June 30, 2012			December 31, 2011
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	358		$	318
Receivables, less allowances for discounts and doubtful accounts of $32 and $37 in 2012 and 2011, respectively		770			756
Inventories, net		467			426
Prepaid and other current assets		107			97
Deferred income tax assets		47			45

Total current assets		1,749			1,642
Property, plant and equipment, net		459			463
Goodwill		1,601			1,610
Other intangible assets, net		485			505
Other non-current assets		188			173

Total assets	$	4,482		$	4,393

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	327		$	322
Accrued and other current liabilities		445			490
Short-term borrowings and current maturities of long-term debt		7			5

Total current liabilities		779			817
Long-term debt		1,199			1,201
Accrued postretirement benefits		313			316
Deferred income tax liability		176			165
Other non-current accrued liabilities		67			67

Total liabilities		2,534			2,566

Commitments and contingencies (Note 14)
Stockholders’ equity:
Common Stock – authorized 750.0 shares, par value $0.01 per share:
Issued 185.7 shares and 184.6 shares in 2012 and 2011, respectively		2			2
Capital in excess of par value		1,690			1,663
Retained earnings		153			40
Treasury stock – at cost 0.1 shares and 0 shares in 2012 and 2011, respectively		(3	)		—
Accumulated other comprehensive income		106			122

Total stockholders’ equity		1,948			1,827

Total liabilities and stockholders’ equity	$	4,482		$	4,393

See accompanying notes to condensed consolidated and combined financial statements.

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)


For the six months ended June 30,	2012			2011
Operating Activities
Net income	$	152		$	150
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		67			68
Share-based compensation		10			5
Payments for restructuring		—			(6	)
Changes in assets and liabilities (net of acquisitions):
Changes in receivables		(16	)		(54	)
Changes in inventories		(44	)		(31	)
Changes in accounts payable		12			(14	)
Changes in accrued liabilities		(24	)		3
Changes in accrued taxes		(5	)		26
Net changes in other assets and liabilities		(20	)		11
Other, net		(7	)		3
Net Cash – Operating activities		125			161
Investing Activities
Capital expenditures		(57	)		(53	)
Proceeds from the sale of property, plant and equipment		3			5
Other, net		1			—
Net Cash – Investing activities		(53	)		(48	)
Financing Activities
Net transfer to former parent		(6	)		(112	)
Issuance of short-term debt		3			—
Principal payments of debt and capital lease obligations		(3	)		—
Purchase of common stock		(3	)		—
Proceeds from exercise of employee stock options		16			—
Dividends paid		(39	)		—
Other, net		1			—
Net Cash – Financing activities		(31	)		(112	)
Effect of exchange rate changes on cash		(1	)		6
Net change in cash and cash equivalents		40			7
Cash and cash equivalents at beginning of year		318			131
Cash and cash equivalents at end of year	$	358		$	138
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest	$	26		$	—
Income taxes (net of refunds received)	$	54		$	18

See accompanying notes to condensed consolidated and combined financial statements.

XYLEM INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Background and Basis of Presentation

Background

Xylem Inc. (“Xylem” or the “Company”) is a leading equipment and service provider for water and wastewater applications with a broad portfolio of products and services addressing the full cycle of water, from collection, distribution and use to the return of water to the environment. Xylem operates in two segments, Water Infrastructure and Applied Water. The Water Infrastructure segment focuses on the transportation, treatment and testing of water, offering a range of products including water and wastewater pumps, treatment and testing equipment, and controls and systems. The Applied Water segment encompasses the uses of water and focuses on the residential, commercial, industrial and agricultural markets. The Applied Water segment’s major products include pumps, valves, heat exchangers, controls and dispensing equipment. Xylem Inc. was incorporated in Indiana on May 4, 2011.

The Spin-off was completed pursuant to the Distribution Agreement, dated as of October 25, 2011 (the “Distribution Agreement”), among ITT, Exelis Inc. (“Exelis”) and Xylem. After the Distribution Date, ITT did not beneficially own any shares of Xylem common stock and, following such date, financial results of Xylem have not been consolidated in ITT’s financial reporting. Xylem’s Registration Statement on Form 10 filed with the U.S. Securities and Exchange Commission (“SEC”) was declared effective on October 6, 2011. Xylem’s common stock began “regular-way” trading on the New York Stock Exchange on November 1, 2011 under the symbol “XYL”.

Hereinafter, except as otherwise indicated or unless the context otherwise requires, “Xylem,” “we,” “us,” “our” and “the Company” refer to Xylem Inc. and its subsidiaries. References in the notes to the condensed consolidated and combined financial statements to “ITT” or “parent” refer to ITT Corporation and its consolidated subsidiaries (other than Xylem Inc.).

Basis of Presentation

The interim condensed consolidated and combined financial statements reflect our financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America (“GAAP”). All intracompany transactions between our businesses have been eliminated. On and prior to October 31, 2011, our financial position, results of operations and cash flows consisted of the water equipment and services businesses of ITT Corporation (“WaterCo”) and have been derived from ITT’s historical accounting records and are presented on a carve-out basis through the Distribution Date, while our financial results for Xylem post Spin-off are prepared on a stand-alone basis. As such, our Condensed Consolidated and Combined Statements of Income,

Comprehensive Income and Cash Flows for the periods ended June 30, 2012 consist of the consolidated results of Xylem on a stand-alone basis and for the periods ended June 30, 2011 consist entirely of the combined results of WaterCo on a carve-out basis.

For periods prior to the Spin-off, our condensed consolidated and combined financial statements include expense allocations for (i) certain corporate functions historically provided by ITT, including, but not limited to, finance, legal, information technology, human resources, communications, ethics and compliance, and shared services, (ii) employee benefits and incentives, and (iii) share-based compensation. These expenses have been allocated to us on the basis of direct usage when identifiable, with the remainder allocated on the basis of revenue, headcount or other measures.

Both Xylem and ITT consider the basis on which the expenses have been allocated to be a reasonable reflection of the utilization of services provided to or the benefit received by us during the periods presented. The allocations may not, however, reflect the expense we would have incurred as an independent, publicly traded company for the periods presented. Actual costs that may have been incurred if we had been a stand-alone company would depend on a number of factors, including the chosen organizational structure, what functions were outsourced or performed by employees and strategic decisions made in areas such as information technology and infrastructure. Subsequent to the Spin-off, we have performed these functions using our own resources or purchased services, certain of which have been provided by ITT and Exelis under a transition services agreement, at a cost of approximately $1 million per quarter that is expected to extend for a period of 3 to 24 months from the Distribution Date in most circumstances.

The unaudited interim condensed combined financial statements have been prepared pursuant to the rules and regulations of the SEC and, in the opinion of management, reflect all adjustments (which include normal recurring adjustments) considered necessary for a fair presentation of the financial position, results of operations, and cash flows for the periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such SEC rules. We believe that the disclosures made are adequate to make the information presented not misleading. We consistently applied the accounting policies described in our Annual Report on Form 10-K for the year ended December 31, 2011 (“2011 Annual Report”) in preparing these unaudited financial statements, with the exception of accounting standard updates described in Note 2 adopted on January 1, 2012. These financial statements should be read in conjunction with the audited consolidated and combined financial statements and the notes thereto included in our 2011 Annual Report.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Estimates are revised as additional information becomes available. Estimates and assumptions are used for, but not limited to, postretirement obligations and assets, revenue recognition, income tax contingency accruals and valuation allowances, goodwill impairment testing and contingent liabilities. Actual results could differ from these estimates. Additionally, our interim condensed consolidated and combined financial statements may not be indicative of our future performance.

Our quarterly financial periods end on the Saturday closest to the last day of the calendar quarter, except for the fourth quarter which ends on December 31. For ease of presentation, the quarterly financial statements included herein are described as ending on the last day of the calendar quarter.

Note 2. Recently Issued Accounting Pronouncements

Pronouncements Not Yet Adopted

In July 2012, the FASB provided companies with the option to make an initial qualitative evaluation, based on events and circumstances, to determine the likelihood of an impairment of an indefinite-lived intangible asset. The results of this qualitative assessment determine whether it is necessary to perform the currently required quantitative comparison of the indefinite-lived intangible asset’s fair value to its carrying amount. If it is more likely than not that the fair value of the intangible asset is less than its carrying amount, a company would be required to perform the quantitative assessment. This guidance is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012 with early adoption permitted. The adoption of the guidance is not expected to have a material impact on our financial condition, results of operations or cash flows.

Recently Adopted Pronouncements

In September 2011, in conjunction with the assessment of the impairment of goodwill, the Financial Accounting Standards Board (“FASB”) provided companies with the option to make an initial qualitative evaluation, based on the entity’s events and circumstances, to determine the likelihood of goodwill impairment. The results of this qualitative assessment determine whether it is necessary to perform the required two-step impairment test. If it is more likely than not that the fair value of a reporting unit is less than its carrying amount, a company would be required to perform the two-step impairment test. On January 1, 2012, we adopted this guidance on a prospective basis. The adoption of the guidance is not expected to have a material impact on our financial condition, results of operations or cash flows.

In June 2011, the FASB issued authoritative guidance surrounding the presentation of comprehensive income, with an objective of increasing the prominence of items reported in other comprehensive income (“OCI”). The guidance requires most entities to present items of net income and other comprehensive income either in one continuous statement, referred to as the statement of comprehensive income, or in two separate, but consecutive, statements of net income and other comprehensive income. We have adopted this guidance with retrospective application as of January 1, 2012, and have presented total comprehensive income in our Condensed Consolidated and Combined Statements of Comprehensive Income.

In May 2011, the FASB issued guidance intended to achieve common fair value measurements and related disclosures between U.S. GAAP and international accounting standards. The amendments primarily clarify existing fair value guidance and are not intended to change the application of existing fair value measurement guidance. However, the amendments include certain instances where a particular principle or requirement for measuring fair value or disclosing information about fair value measurements has changed. On January 1, 2012, we adopted this guidance. The adoption of the guidance did not have a material impact on our financial condition, results of operations or cash flows.

Note 3. Separation Costs

The components of non-recurring separation costs incurred as a result of the Spin-off are presented below.


(in millions)	Three Months Ended					Six Months Ended
	June 30,					June 30,
	2012			2011		2012			2011
Rebranding and marketing costs	$	2		$	1	$	4		$	1
Employee retention and hiring costs		1			3		1			4
Information and technology costs		1			7		1			7
Advisory fees and other		2			7		5			9

Total separation costs in operating income		6			18		11			21
Income tax (benefit) expense		(2	)		9		(3	)		8

Total separation costs, net of tax	$	4		$	27	$	8		$	29

Note 4. Income Taxes

Our quarterly provision for income taxes is measured using an estimated annual effective tax rate, adjusted for discrete items within periods presented. The comparison of our effective tax rate between periods is significantly impacted by the level and mix of earnings and losses by tax jurisdiction, foreign income tax rate differentials and amount of permanent book-to-tax differences.

The income tax provision for the three months ended June 30, 2012 was $26 million at an effective tax rate of 23.3%, compared to $43 million at an effective tax rate of 37.4% for the same period in 2011. The income tax provision for the six months ended June 30, 2012 was $47 million at an effective tax rate of 23.9%, compared to $66 million at an effective tax rate of 30.6% for the same period in 2011. The decrease in the effective tax rate for the three and six months ended June 30, 2012 as compared to the same periods in 2011 was primarily due to a reduction in the tax separation costs, partly offset by our geographic mix of earnings in 2012.

Unrecognized Tax Benefits

We recognize tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized from such positions are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.

The amount of unrecognized tax benefits at June 30, 2012 was $6 million which, if ultimately recognized, will reduce our annual effective tax rate. We do not believe that the unrecognized tax benefits will significantly change within the next twelve months.

We classify interest relating to unrecognized tax benefits as a component of other non-operating income, net and tax penalties as a component of income tax expense in our Condensed Consolidated and Combined Income Statements. As of June 30, 2012, we had less than $1 million of interest accrued for unrecognized tax benefits.

Note 5. Earnings Per Share

The following is a summary of the calculation of basic and diluted net earnings per share.


	Three Months Ended June 30,				Six Months Ended June 30,
	2012		2011 (a)		2012		2011 (a)
Net income (in millions)	$	89	$	72	$	152	$	150
Shares (in thousands):
Weighted average common shares outstanding		185,546		184,570		185,254		184,570
Add: Participating securities (b)		303		—		370		—

Weighted average common shares outstanding — Basic		185,849		184,570		185,624		184,570
Plus incremental shares from assumed conversions: (c)
Dilutive effect of stock options		217		—		253		—
Dilutive effect of restricted stock		181		—		177		—

Weighted average common shares outstanding — Diluted		186,248		184,570		186,054		184,570

Basic earnings per share	$	0.48	$	0.39	$	0.82	$	0.82
Diluted earnings per share	$	0.48	$	0.39	$	0.82	$	0.82

(a)

Basic and diluted earnings per share for all periods prior to the Spin-off reflect the number of distributed shares on the Distribution Date, or 184.6 million shares. At the time of the Spin-off, ITT stock options and restricted stock awards were converted to awards of Xylem, and therefore there were no dilutive securities outstanding for the period prior to Spin-off.

(b)	Restricted stock awards containing rights to non-forfeitable dividends which participate in undistributed earnings with common shareholders are considered participating securities for purposes of computing earnings per share.

(c)

Incremental shares from stock options and restricted stock are computed by the treasury stock method. The average shares listed below were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive for the periods presented or because they were excluded under the treasury stock method. The treasury stock method calculates dilution assuming the exercise of all in-the-money options and vesting of restricted stock awards, reduced by the repurchase of shares with the proceeds from the assumed exercises, unrecognized compensation expense for outstanding awards and the estimated tax benefit of the assumed exercises.

Three Months Ended
June 30,

Six Months Ended
June 30,

(in thousands)

2012

2011

2012

2011

Stock options

4,510

—

4,408

—

Restricted shares

993

—

918

—

Note 6. Inventories


(in millions)	June 30, 2012		December 31, 2011
Finished goods	$	183	$	168
Work in process		41		31
Raw materials		243		227

Total inventories, net	$	467	$	426

Note 7. Property, Plant and Equipment


(in millions)	June 30, 2012		December 31, 2011
Land, buildings and improvements	$	240	$	237
Machinery and equipment		616		598
Equipment held for lease or rental		168		152
Furniture and fixtures		91		86
Construction work in progress		37		53
Other		22		21

		1,174		1,147
Less accumulated depreciation		715		684

Total property, plant and equipment, net	$	459	$	463

Depreciation expense of $21 million and $44 million was recognized in the three and six month periods ended June 30, 2012, respectively, and $25 million and $47 million for the three and six month periods ended June 30, 2011, respectively.

Note 8. Goodwill and Other Intangible Assets

Changes in the carrying value of goodwill by operating segment for the six months ended June 30, 2012 are as follows:


(in millions)	Water Infrastructure			Applied Water			Total
Balance as of December 31, 2011	$	1,054		$	556		$	1,610
Activity in 2012
Foreign currency and other		(6	)		(3	)		(9	)

Balance as of June 30, 2012	$	1,048		$	553		$	1,601

Based on the results of our annual impairment tests, we determined that no impairment of goodwill existed as of the measurement date in 2011. However, future goodwill impairment tests could result in a charge to earnings. We will continue to evaluate goodwill on an annual basis as of the beginning of our fourth quarter and whenever events and changes in circumstances indicate there may be a potential impairment.

Other Intangible Assets

Information regarding our other intangible assets is as follows:


	June 30, 2012							December 31, 2011
(in millions)	Carrying Amount		Accumulated Amortization			Net Intangibles		Carrying Amount		Accumulated Amortization			Net Intangibles
Customer and distributor relationships	$	305	$	(62	)	$	243	$	309	$	(51	)	$	258
Proprietary technology		102		(26	)		76		102		(23	)		79
Trademarks		32		(12	)		20		32		(11	)		21
Patents and other		21		(16	)		5		21		(15	)		6
Indefinite-lived intangibles		141		—			141		141		—			141

	$	601	$	(116)		$	485	$	605	$	(100)		$	505

Based on the results of our annual impairment tests, we determined that no impairment of the indefinite-lived intangibles existed as of the measurement date in 2011. However, future impairment tests could result in a charge to earnings. We will continue to evaluate the indefinite-lived intangible assets on an annual basis as of the beginning of our fourth quarter and whenever events and changes in circumstances indicate there may be a potential impairment.

Amortization expense related to finite lived intangible assets of $9 million and $17 million was recognized in the three and six month periods ended June 30, 2012, respectively, and $8 million and $16 million for the three and six month periods ended June 30, 2011, respectively.

Note 9. Derivative Financial Instruments

We record all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on whether we have elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, including forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. We may enter into derivative contracts that are intended to economically hedge certain risks, even though hedge accounting does not apply or we elect not to apply hedge accounting.

Risk Management Objective of Using Derivatives

We are exposed to certain risks arising from both our business operations and economic conditions and principally manage our exposures to these risks through management of our core business activities. Certain of our foreign operations expose us to fluctuations of foreign interest rates and exchange rates that may impact revenues, expenses, cash receipts and payments. We enter into derivative financial instruments to protect the value or fix the amount of certain cash flows in terms of the functional currency of the business unit with that exposure.

Cash Flow Hedges of Foreign Exchange Risk

We are exposed to fluctuations in various foreign currencies against our functional currencies. We use foreign currency derivatives including currency forward agreements to manage our exposure to fluctuations in the various exchange rates. Currency forward agreements involve fixing the foreign currency exchange rate for delivery of a specified amount of foreign currency on a specified date.

Beginning in 2012, certain business units within our segments with exposure to foreign currency exchange risks have designated certain currency forward agreements as cash flow hedges of forecasted intercompany inventory purchases and sales. The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges of foreign exchange risk is recorded in accumulated other comprehensive income and is subsequently reclassified into either revenue or cost of revenue (hedge of sales classified into revenue and hedge of purchases classified into cost of revenue) in the period that the hedged forecasted transaction affects earnings. Any ineffective portion of the change in fair value of the derivative is recognized directly in selling, general

and administrative expenses. Our policy is to de–designate cash flow hedges at the time forecasted transactions are recognized as assets or liabilities on a business unit’s balance sheet and report subsequent changes in fair value through selling, general and administrative expenses where the gain or loss due to movements in currency rates on the underlying asset or liability is revalued. If it becomes probable that the originally forecasted transaction will not occur, the gain or loss related to the hedge recorded within accumulated other comprehensive income is recognized into net income.

Listed in the table below are the outstanding foreign currency derivatives that were used to hedge foreign exchange risks as of June 30, 2012.


(in millions; except number of instruments)
Foreign Currency Derivative	Number of Instruments	Notional Sold	Sell Notional Currency	Notional Purchased	Buy Notional Currency
Buy PLN/ Sell EUR forward	5	5.6	Euro (EUR)	25.0	Polish Zloty (PLN)
Buy HUF/ Sell EUR forward	5	3.4	Euro (EUR)	1,080.0	Hungarian Forint (HUF)
Sell CAD/ Buy SEK forward	9	9.3	Canadian Dollar (CAD)	63.4	Swedish Krona (SEK)
Sell EUR/ Buy SEK forward	6	14.5	Euro (EUR)	129.3	Swedish Krona (SEK)
Sell USD/ Buy SEK forward	15	30.0	United States Dollar (USD)	208.2	Swedish Krona (SEK)
Sell AUD/ Buy SEK forward	7	7.5	Australian Dollar (AUD)	52.6	Swedish Krona (SEK)

The tables below present the effect of our derivative financial instruments on the Condensed Consolidated and Combined Income Statements.


	Three Months Ended June 30,					Six Months Ended June 30,
	2012			2011		2012			2011
Derivatives in Cash Flow Hedging Relationships Foreign Exchange Contracts
Amount of gain (loss) recognized in OCI (a)	$	(2	)	$	—	$	2		$	—
Amount of (gain) loss reclassified from OCI into cost of revenue (a)		(1	)		—		(1	)		—
Amount of gain (loss) recognized in net income (b)		—			—		—			—

(a)	Effective portion

(b)	Ineffective portion and amount excluded from effectiveness testing

As of June 30, 2012, $1 million of the net unrealized gains on cash flow hedges is expected to be reclassified into earnings in the next 12 months. The ineffective portion of the change in fair value of a cash flow hedge is recognized immediately in selling, general and administrative expenses in the Condensed Consolidated and Combined Income Statements and, for the three and six months ended June 30, 2012, was not material.

The fair values of our foreign exchange contracts were as follows:


(in millions)	June 30, 2012
Derivatives designated as hedging instruments
Assets
Other current assets	$	1

Total fair value	$	1

Note 10. Accrued and Other Current Liabilities


(in millions)	June 30, 2012		December 31, 2011
Compensation and other employee-benefits	$	201	$	211
Customer-related liabilities		48		53
Accrued warranty costs		40		42
Accrued income taxes		66		77
Deferred income tax liability		9		8
Other accrued liabilities		81		99

Total accrued and other current liabilities	$	445	$	490

Note 11. Credit Facilities and Long-Term Debt


(in millions)	June 30, 2012			December 31, 2011
Short-term borrowings and current maturities of long-term debt	$	7		$	5
Long-term debt
3.550% Senior Notes due 2016 (a)		600			600
4.875% Senior Notes due 2021 (a)		600			600
Other		—			2
Unamortized discount (b)		(1	)		(1	)

Long-term debt	$	1,199		$	1,201

Total debt	$	1,206		$	1,206

(a)

The fair value of our Senior Notes as of June 30, 2012 and December 31, 2011 was determined using prices for the identical security obtained from an external pricing service, which are considered Level 2 inputs. As of June 30, 2012 and December 31, 2011, the fair value of our Senior Notes due 2016 was $630 million and $625 million, respectively, and the fair value of our Senior Notes due 2021 was $676 million and $642 million, respectively.

(b)	The unamortized discount is recognized as a reduction in the carrying value of the Senior Notes in the Condensed Consolidated Balance Sheets and is being amortized to interest expense in our Condensed Consolidated and Combined Income Statements over the expected remaining terms of the Senior Notes.

Senior Notes

The issuance resulted in gross proceeds of $1.2 billion, offset by $9 million in debt issuance costs which were capitalized and are included within other assets. The Senior Notes include covenants which restrict our ability, subject to exceptions, to incur debt secured by liens and engage in sale and lease-back transactions, as well as provide for customary events of default (subject, in certain cases, to receipt of notice of default and/or customary grace and cure periods), including but not limited to, (i) failure to pay interest for 30 days, (ii) failure to pay principal when due, (iii) failure to perform any other covenant for 90 days after receipt of notice from the trustee or from holders of 25% of the outstanding principal amount and (iv) certain events of bankruptcy, insolvency or reorganization. We may redeem the Senior Notes, as applicable, in whole or in part, at any time at a redemption price equal to the principal amount of the Senior Notes to be redeemed, plus a make-whole premium. As of June 30, 2012, we were in compliance with all covenants. If a change of control of Xylem triggering event occurs, we will be required to make an offer to purchase the Senior Notes at a price equal to 101% of their principal amount plus accrued and unpaid interest to the date of repurchase.

Interest on the Senior Notes accrues from September 20, 2011. Interest on the 2016 Notes is payable on March 20 and September 20 of each year, commencing on March 20, 2012. Interest on the 2021 Notes is payable on April 1 and October 1 of each year, commencing on April 1, 2012.

In connection with the issuance of the Senior Notes on September 20, 2011, ITT, Xylem and the initial purchasers of the Senior Notes entered into a registration rights agreement with respect to the Senior Notes. Pursuant to that agreement, on June 14, 2012, Xylem filed a registration statement with respect to offers to exchange the Senior Notes for new registered notes, with terms substantially identical in all material respects to the Senior Notes except for the elimination of the transfer restrictions and related rights.

Four Year Competitive Advance and Revolving Credit Facility

Effective October 31, 2011, Xylem and its subsidiaries entered into a Four Year Competitive Advance and Revolving Credit Facility (the “Credit Facility”) with JPMorgan Chase Bank, N.A., as agent, and a syndicate of lenders. The credit facility provides for an aggregate principal amount of up to $600 million of (i) a competitive advance borrowing option which will be provided on an uncommitted competitive advance basis through an auction mechanism (the “competitive loans”), (ii) revolving extensions of credit (the “revolving loans”) outstanding at any time and (iii) the issuance of letters of credits in a face amount not in excess of $100 million outstanding at any time.

At our election, the interest rate per annum applicable to the competitive advances will be based on either (i) a Eurodollar rate determined by reference to LIBOR, plus an applicable margin offered by the lender making such loans and accepted by us or (ii) a fixed percentage rate per annum specified by the lender making such loans. At our election, interest rate per annum applicable to the revolving loans will be based on either (i) a Eurodollar rate determined by reference to LIBOR, adjusted for statutory reserve requirements, plus an applicable margin or (ii) a fluctuating rate of interest determined by reference to the greatest of (a) the prime rate of JPMorgan Chase Bank, N.A., (b) the U.S. Federal Funds effective rate plus half of 1% or (c) the Eurodollar rate determined by reference to LIBOR, adjusted for statutory reserve requirements, in each case, plus an applicable margin.

In accordance with the terms, we may not exceed a maximum leverage ratio of 3.50 (based on a ratio of total debt to earnings before interest, taxes, depreciation and amortization) throughout the term. The Credit Facility also contains limitations on, among other things, incurring debt, granting liens, and entering sale and leaseback transactions. In addition, the Credit Facility contains other terms and conditions such as customary representations and warranties, additional covenants and customary events of default.

Note 12. Postretirement Benefit Plans

The following table provides the components of net periodic benefit cost and other amounts recognized in other comprehensive income for defined benefit pension plans, disaggregated by domestic and international plans.


	Three Months Ended June 30,						Six Months Ended June 30,
(in millions)	2012			2011 (a)			2012			2011 (a)
Domestic defined benefit pension plans
Net periodic benefit cost:
Service cost	$	—		$	1		$	1		$	1
Interest cost		1			1			2			2
Expected return on plan assets		(1	)		(1	)		(2	)		(2	)
Amortization of net actuarial loss		1			—			1			—

Net periodic benefit cost	$	1		$	1		$	2		$	1

Other changes in plan assets and benefit obligations recognized in other comprehensive income
Net loss (gain)	$	—		$	—		$	—		$	—
Prior service cost		—			—			—			—
Amortization of net actuarial loss		(1	)		—			(1	)		—

Change recognized in other comprehensive income	$	(1	)	$	—		$	(1	)	$	—

International defined benefit pension plans:
Net periodic benefit cost:
Service cost	$	2		$	1		$	5		$	2
Interest cost		7			2			14			4
Expected return on plan assets		(7	)		(1	)		(15	)		(1	)
Amortization of net actuarial loss		2			1			4			1
Settlement		—			—			2			—

Net periodic benefit cost	$	4		$	3		$	10		$	6

Other changes in plan assets and benefit obligations recognized in other comprehensive income
Net loss	$	—		$	—		$	—		$	—
Amortization of net actuarial loss		(2	)		(1	)		(4	)		(1	)
Settlement		—			—			(2	)		—

Change recognized in other comprehensive income	$	(2	)	$	(1	)	$	(6	)	$	(1	)

Totals:
Net periodic benefit cost	$	5		$	4		$	12		$	7
Recognized in other comprehensive income		(3	)		(1	)		(7	)		(1	)

Total recognized in comprehensive income	$	2		$	3		$	5		$	6

(a)	Represents periods prior to Spin-off from ITT and does not include plans transferred from ITT in connection with the Spin-off, which were accounted for previously as multi-employer plans.

We contributed $19 million and $6 million during the six months ended June 30, 2012 and 2011, respectively. The contributions for the six months ended June 30, 2012 included $2 million to purchase an annuity in connection with the settlement of five international pension plans. Additional contributions ranging between $15 million and $20 million are expected during the remainder of 2012.

Note 13. Stock-Based Compensation Plans

The following table provides detail related to share-based compensation expense.


Three Months Ended June 30,
(in millions)	2012		2011
	Xylem Employees		Xylem Employees		Other Employee Allocations		2011 Total
Equity-based Compensation	$	5	$	1	$	1	$	2
Liability-based Compensation		—		—		1		1


Six Months Ended June 30,
(in millions)	2012		2011
	Xylem Employees		Xylem Employees		Other Employee Allocations		2011 Total
Equity-based Compensation	$	10	$	2	$	3	$	5
Liability-based Compensation		—		—		1		1

For 2011, a significant component of these charges related to costs allocated to Xylem for ITT corporate employees as well as other ITT employees not solely dedicated to Xylem. These allocated costs are not necessarily indicative of awards and amounts that would have been granted if we were an independent, publicly traded company for the periods presented.

The unamortized compensation expense related to our stock options and restricted shares was $16 million and $27 million, respectively, at June 30, 2012 and is expected to be recognized over a weighted average period of 2.4 and 2.3 years, respectively. The amount of cash received from the exercise of stock options was $16 million for the six months ended June 30, 2012. We classify as a financing activity the cash flows attributable to excess tax benefits arising from stock option exercises and restricted stock lapses.

Restricted Stock Grants

The following is a summary of restricted stock activity for the six months ended June 30, 2012:


(in thousands, except for per share amounts)	Shares			Weighted Average Grant Date Fair Value /Share
Outstanding at December 31, 2011		1,488		$	25.93

Granted		533		$	26.60
Vested		(296	)	$	21.19
Forfeited		(99	)	$	27.14

Outstanding at June 30, 2012		1,626		$	26.95

Stock Option Grants

The following is a summary of the changes in outstanding stock options for the six months ended June 30, 2012:


(in thousands, except for per share amounts)	Shares			Weighted Average Exercise Price /Share		Weighted Average Remaining Contractual Term (Years)
Outstanding at December 31, 2011		4,590		$	25.83		5.4

Granted		852		$	26.60		10.0
Exercised		(644	)	$	24.63		0.1
Forfeited		(199	)	$	26.81		9.0

Outstanding at June 30, 2012		4,599		$	26.10		6.2

Options exercisable at June 30, 2012		2,012		$	25.26		2.4

The aggregate intrinsic value of all outstanding and exercisable stock options as of June 30, 2012 was $6 million and $5 million, respectively. The total intrinsic value of options exercised (which is the amount by which the stock price exceeded the exercise price of the options on the date of exercise) during the six months ended June 30, 2012 was $1 million.

Stock Option Fair Value

The fair value of each option grant was estimated on the date of grant using the binomial lattice pricing model which incorporates multiple and variable assumptions over time, including assumptions such as employee exercise patterns, stock price volatility and changes in dividends. The following are weighted-average assumptions for our annual March 2012 grants.


Dividend yield		1.52	%
Volatility		33.4	%
Risk-free interest rate		1.42	%
Expected term (in years)		7.0
Weighted-average fair value / share	$	8.10

Expected volatility is calculated based on an analysis of historic and implied volatility measures for a set of peer companies. We use historical data to estimate option exercise and employee termination behavior within the valuation model. Employee groups and option characteristics are considered separately for valuation purposes. The expected term represents an estimate of the period of time options are expected to remain outstanding. The expected term provided above represents the weighted average of expected behavior for certain groups of employees who have historically exhibited different behavior. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of option grant.

Note 14. Commitments and Contingencies

General

From time to time, we are involved in legal proceedings that are incidental to the operation of our businesses. Some of these proceedings seek remedies relating to environmental matters, intellectual

property matters, product liability and personal injury claims, employment and pension matters, government contract issues and commercial or contractual disputes, which are sometimes related to acquisitions or divestitures. Although we cannot predict the outcome of these and other proceedings with certainty, we believe that they will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.

On December 20, 2011, the Ad Hoc Committee of ITT Bondholders filed a Complaint in New York State court alleging that ITT breached the early redemption provisions of certain bonds issued in 2009. In 2009, ITT issued $500 million in bonds maturing in 2019 at an interest rate of 6.125%. The documents governing the bonds contained certain provisions addressing early redemptions. On September 20, 2011, ITT notified the holders of the debt that it intended to redeem the bonds on October 20, 2011 in accordance with the terms of the governing documents. On October 18, 2011, the redemption price was disclosed. The Plaintiffs contend that ITT used an improper discount rate in calculating the redemption price and otherwise failed to comply with required redemption procedures. The Plaintiffs alleged damages in excess of $5 million and further alleged that if such damages are extended to all holders of these bonds, the damages would be in excess of $15 million. The costs associated with this matter are shared with ITT and Exelis in accordance with the Distribution Agreement (21% ITT, 39% Exelis and 40% Xylem). The Complaint was resolved on July 10, 2012 and the resolution will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.

While very few claims have been asserted against Xylem alleging injury caused by any of our products resulting from asbestos exposure, it is possible that additional claims could be filed in the future. We believe there are numerous legal defenses available for such claims and, should such a claim not be indemnifiable by ITT, we would defend ourselves vigorously. Pursuant to the Distribution Agreement, ITT will indemnify Xylem for asbestos product liability matters, including settlements, judgments, and legal defense costs associated with all pending and future claims that may arise from past sales of ITT’s legacy products. We believe ITT remains a substantial entity with sufficient financial resources to honor its obligations to us.

Although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including our assessment of the merits of the particular claims, we do not expect that any asserted or unasserted legal claims or proceedings, individually or in aggregate, will have a material adverse effect on our cash flow, results of operations, or financial condition.

Indemnifications

As part of the Spin-off, ITT, Exelis and Xylem will indemnify each of the other parties with respect to such parties’ assumed or retained liabilities under the Distribution Agreement and breaches of the Distribution Agreement or related spin agreements. ITT’s indemnification obligations include asserted and unasserted asbestos and silica liability claims that relate to the presence or alleged presence of asbestos or silica in products manufactured, repaired or sold prior to the Distribution Date, subject to limited exceptions with respect to certain employee claims, or in the structure or material of any building or facility, subject to exceptions with respect to employee claims relating to Xylem buildings or facilities. The indemnification associated with pending and future asbestos claims does not expire. Xylem has not recorded a liability for material matters for which we will be indemnified by ITT or Exelis through the Distribution Agreement and we are not aware of any claims or other circumstances that would give rise to material payments from us under such indemnifications.

Environmental

In the ordinary course of business, we are subject to federal, state, local, and foreign environmental laws and regulations. We are responsible, or are alleged to be responsible, for ongoing environmental investigation and remediation of sites in various countries. These sites are in various stages of investigation and/or remediation and in many of these proceedings our liability is considered de minimis. We have received notification from the U.S. Environmental Protection Agency, and from similar state and foreign environmental agencies, that a number of sites formerly or currently owned and/or operated by Xylem, and other properties or water supplies that may be or have been impacted from those operations, contain disposed or recycled materials or wastes and require environmental investigation and/or remediation. These sites include instances where we have been identified as a potentially responsible party under federal and state environmental laws and regulations.

Accruals for environmental matters are recorded on a site-by-site basis when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. Our accrued liabilities for these environmental matters represent the best estimates related to the investigation and remediation of environmental media such as water, soil, soil vapor, air and structures, as well as related legal fees. These estimates, and related accruals, are reviewed quarterly and updated for progress of investigation and remediation efforts and changes in facts and legal circumstances. Liabilities for these environmental expenditures are recorded on an undiscounted basis. We have estimated and accrued $13 million and $15 million as of June 30, 2012 and December 31, 2011, respectively, for environmental matters.

It is difficult to estimate the final costs of investigation and remediation due to various factors, including incomplete information regarding particular sites and other potentially responsible parties, uncertainty regarding the extent of investigation or remediation and our share, if any, of liability for such conditions, the selection of alternative remedial approaches, and changes in environmental standards and regulatory requirements. In our opinion, the total amount accrued is reasonable based on existing facts and circumstances.

Operating Leases

We lease certain offices, manufacturing buildings, machinery, computers and other equipment. Such leases expire at various dates through 2047 and may include renewal and payment escalation clauses. We often pay maintenance, insurance and tax expense related to leased assets. Subsequent to the issuance of our 2011 Annual Report, we identified that we had incorrectly aggregated data from certain of our foreign subsidiaries related to our annual disclosure of rent expense for the year ended December 31, 2011 and our future minimum rental payments. As a result, we have adjusted and disclosed certain corrected amounts herein. These adjustments did not impact the Consolidated and Combined Income Statements, Balance Sheet, Statements of Cash Flows or Statement of Stockholders’ Equity and Comprehensive Income.

At December 31, 2011, we were obligated to make minimum rental payments under operating leases which are as follows. There have been no material changes to our minimum rental obligations subsequent to December 31, 2011.


(in millions)	2012		2013		2014		2015		2016		Thereafter
Minimum rental payments (1)	$	54	$	42	$	29	$	22	$	17	$	36

The disclosed rent expense for the year-ended December 31, 2011, as adjusted, is $64 million.

Warranties

We warrant numerous products, the terms of which vary widely. In general, we warrant products against defect and specific non-performance. The table below provides the changes in our product warranty accrual.


(in millions)	2012			2011
Warranty accrual – January 1	$	42		$	38
Net changes for product warranties in the period		15			13
Settlement of warranty claims		(16	)		(15	)
Other		(1	)		1

Warranty accrual – June 30	$	40		$	37

Note 15. Related Party Transactions

During the three months and six months ended June 30, 2011, we sold inventory to other ITT businesses in the aggregate amount of $3 million and $7 million, respectively, which is included in revenue in our condensed consolidated and combined financial statements. In addition, we recognized cost of sales from the inventory purchased from other ITT businesses of $3 million and $6 million for the three months and six months ended June 30, 2011, respectively.

Prior to the Spin-off, the condensed consolidated and combined financial statements include expense allocations for certain functions provided by ITT, as well as other ITT employees not solely dedicated to Xylem, including, but not limited to, general corporate expenses related to finance, legal, information technology, human resources, communications, ethics and compliance, shared services, employee benefits and incentives, and share-based compensation. These expenses have been allocated to us on the basis of direct usage when identifiable, with the remainder allocated on the basis of revenue, headcount or other measure. During the three months and six months ended June 30, 2011, we were allocated general corporate expenses incurred by ITT which are included within selling, general and administrative expenses in the Condensed Consolidated and Combined Income Statements for 2011 of $38 million, which included $14 million of separation costs, and $64 million, which included $17 million of separation costs, respectively.

The expense allocations have been determined on a basis that we consider to be a reasonable reflection of the utilization of services provided or the benefit received by us during the periods presented. The allocations may not, however, reflect the expense we would have incurred as an independent, publicly traded company for the periods presented. Actual costs that may have been incurred if we had been a standalone company would depend on a number of factors, including the chosen organizational structure, what functions were outsourced or performed by employees and strategic decisions made in areas such as information technology and infrastructure.

Note 16. Segment Information

Our business is organized into two segments: Water Infrastructure and Applied Water. The Water Infrastructure segment, comprising our Water Solutions (f/k/a Water & Wastewater) and Analytics operating units, focuses on the transportation, treatment and testing of water, offering a range of products including water and wastewater pumps, treatment and testing equipment, and controls and systems. The Applied Water segment, comprising our Residential & Commercial Water and Flow

Control operating units, encompasses the uses of water and focuses on the residential, commercial, industrial and agricultural markets offering a wide range of products including pumps, valves, heat exchangers, controls and dispensing equipment. Corporate and other consists of corporate office expenses including compensation, benefits, occupancy, depreciation, and other administrative costs, as well as charges related to certain matters, such as the Spin-off and environmental matters that are managed at a corporate level and are not included in the business segments in evaluating performance or allocating resources.

The accounting policies of each segment are the same as those described in the summary of significant accounting policies (see Note 1 in the 2011 Annual Report). The following tables contain financial information for each reportable segment.


	Three Months Ended June 30,						Six Months Ended June 30,
(in millions)	2012			2011			2012			2011
Revenue:
Water Infrastructure	$	609		$	602		$	1,193		$	1,153
Applied Water		373			385			728			740
Eliminations		(16	)		(16	)		(30	)		(32	)

Total	$	966		$	971		$	1,891		$	1,861

Operating Income:
Water Infrastructure	$	93		$	94		$	167		$	158
Applied Water		52			50			92			96
Corporate and other		(16	)		(28	)		(31	)		(38	)

Total	$	129		$	116		$	228		$	216

Depreciation and Amortization:
Water Infrastructure	$	24		$	28		$	50		$	53
Applied Water		7			7			14			15
Corporate and other		2			—			3			—

Total	$	33		$	35		$	67		$	68

Capital Expenditures:
Water Infrastructure	$	21		$	26		$	41		$	41
Applied Water		3			7			13			10
Corporate and other		2			1			3			2

Total	$	26		$	34		$	57		$	53

The following table contains the total assets for each reportable segment.


	Total Assets
(in millions)	June 30, 2012		December 31, 2011
Water Infrastructure	$	2,734	$	2,745
Applied Water		1,273		1,234
Corporate and other		475		414

Total	$	4,482	$	4,393

Corporate and other consists of items pertaining to our corporate headquarters function, which principally consist of cash, deferred tax assets, pension assets and certain property, plant and equipment.

Note 17. Subsequent Events

On July 13, 2012 we acquired MJK Automation (“MJK”), a leading manufacturer of flow and level sensors, and measurement and control technology for water and wastewater applications, for approximately $12.3 million. MJK generated revenue of approximately $10.7 million for the fiscal year ended June 30, 2012 and employs 50 people at sites within Denmark, Norway, the Netherlands, and the United States.

On July 26, 2012, the Company completed its offers to exchange the Senior Notes for new registered notes, with terms substantially identical in all material respects to the Senior Notes except for the elimination of the transfer restrictions and related rights.

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Report contains information that may constitute “forward-looking statements.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “target” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking.

These forward-looking statements include, but are not limited to, statements about the separation of Xylem Inc. (the “Company”) from ITT Corporation, the terms and the effect of the separation, the nature and impact of the separation, capitalization of the Company, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals, and any discussion of future operating or financial performance. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future — including statements relating to orders, sales, operating margins and earnings per share growth, and statements expressing general views about future operating results — are forward-looking statements.

Caution should be taken not to place undue reliance on any such forward-looking statements because they involve risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the Company’s historical experience and our present expectations or projections. For a more detailed discussion of these factors, see the information under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2011 (“2011 Annual Report”) and with other filings we make with the SEC.

The following discussion should be read in conjunction with the condensed consolidated and combined financial statements, including the notes thereto, included elsewhere in this Report. Except as otherwise indicated or unless the context otherwise requires, “Xylem,” “we,” “us,” “our” and “the Company” refer to Xylem Inc. and its subsidiaries. References in the condensed consolidated and combined financial statements to “ITT” or “parent” refer to ITT Corporation and its consolidated subsidiaries (other than Xylem Inc.).

On October 31, 2011, ITT Corporation (“ITT”) completed the Spin-off of Xylem, formerly ITT’s water equipment and services businesses (the “Spin-off”). Effective as of 12:01 a.m., Eastern time on October 31, 2011 (the “Distribution Date”), the common stock of Xylem was distributed, on a pro rata basis, to ITT’s shareholders of record as of the close of business on October 17, 2011 (the “Record Date”). On and prior to October 31, 2011, our financial position, results of operations and cash flows consisted of the water equipment and services businesses of ITT Corporation (“WaterCo”) and have been derived from ITT’s historical accounting records and are presented on a carve-out basis through the Distribution Date, while our financial results for Xylem following the Spin-off are prepared on a stand-alone basis. As such, our Condensed Consolidated and Combined Income and Comprehensive Income Statements for the three and six month periods ended June 30, 2012 and our Condensed Consolidated and Combined Statement of Cash Flows for the six months ended June 30, 2012 consist of the consolidated results of Xylem on a stand-alone basis and for the three and six months ended June 30, 2011 consist entirely of the combined results of WaterCo on a carve-out basis.

Overview

Xylem Inc. (“Xylem” or the “Company”) is a leading equipment and service provider for water and wastewater applications with a broad portfolio of products and services addressing the full cycle of water, from collection, distribution and use to the return of water to the environment. Xylem operates in two segments, Water Infrastructure and Applied Water. The Water Infrastructure segment focuses on the transportation, treatment and testing of water, offering a range of products including water and wastewater pumps, treatment and testing equipment, and controls and systems. The Applied Water segment encompasses all the uses of water and focuses on the residential, commercial, industrial and agricultural markets. The segment’s major products include pumps, valves, heat exchangers, controls and dispensing equipment. Xylem Inc. was incorporated in Indiana on May 4, 2011.

Our business focuses on providing technology-intensive equipment and services within the water industry supply chain. We sell our equipment and services via direct and indirect channels that serve the needs of each customer type. On the public utility side, we provide over 70% direct sales with strong application expertise, with the remaining amount going through distribution partners. To end users of water, we provide over 85% of our sales through long-standing relationships with the world’s leading distributors, with the remainder going direct to customers. The total market opportunity for this equipment and services portion of the water industry supply chain is estimated at $280 billion.

Our product and service offerings are organized into two segments: Water Infrastructure and Applied Water. Our segments are aligned with each of the sectors in the cycle of water, supply infrastructure and usage applications.

•

Water Infrastructure serves the supply infrastructure sector with pump systems that transport water from aquifers, lakes, rivers and seas; with filtration, ultraviolet and ozone systems that provide treatment, making the water fit to use; and providing pump lift stations that move the wastewater to treatment facilities where our mixers, biological treatment, disinfection, monitoring, and control systems provide the primary functions in the treatment process. We provide analytical instrumentation used to measure water quality, flow, and level in wastewater, surface water, and coastal environments.

•

Applied Water serves the usage applications sector with water boosting systems for drinking; heating, ventilation and air conditioning and for fire protection systems to the residential and commercial building services markets. In addition, our pumps, heat exchangers, valves and controls provide cooling to power plants and manufacturing facilities, as well as circulation for food and beverage processing. We also provide boosting systems for farming irrigation, pumps for dairy operations, and rainwater reuse systems for small scale crop and turf irrigation.

Executive Summary

Xylem reported revenue for the second quarter 2012 of $966 million, a decrease of 0.5% compared to $971 million during the comparable quarter in 2011. Revenue grew 4.5% on a constant currency basis, driven by our recently acquired YSI business combined with strong industrial performance. Operating income for the second quarter of 2012, excluding separation costs of $6 million, was $135 million, reflecting an increase of $1 million or 0.7% compared to $134 million, excluding separation costs of $18 million in the second quarter of 2011. Operating income in 2012 was muted by costs incurred as a standalone company which were not incurred prior to the Spin-off.

Additional financial highlights for the three months ended June 30, 2012 include the following:

•

Order growth of 2.3% over the prior year period, excluding negative currency translation impact

•

Net income of $89 million, or $0.48 per diluted share

•

Free cash flow generation of $86 million for the six months ended June 30, 2012, down $48 million from the comparable 2011 period

2012 Outlook

The current global economic environment, particularly in Europe, presented difficult market conditions during the second quarter of 2012. Generally, these difficult economic conditions are expected to continue into the second half of 2012, as the instability in the financial markets and geopolitical environment continues. As a result, we are planning restructuring and realignment actions in the second half of 2012, primarily in Europe, to improve operational efficiencies. We expect to incur approximately $15 to $20 million of restructuring and realignment costs during the remainder of 2012.

Additionally, we currently generate approximately 63% of our revenue outside the U.S., which is impacted by changes in foreign currency exchange rates, particularly the Euro, Swedish Krona, British Pound, Australian Dollar, Canadian Dollar, Polish Zloty, and Hungarian Forint. Upon consolidation, as exchange rates vary, our revenue and other operating results may differ from expectations. In this uncertain economy, significant fluctuations in foreign exchange rates may continue.

Key Performance Indicators and Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margin, segment operating income and margins, earnings per share, orders growth, working capital, free cash flow, and backlog, among others. In addition, we consider certain measures to be useful to management and investors evaluating our operating performance for the periods presented, and provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including, but not limited to, dividends and acquisitions, share repurchases and debt repayment. These metrics, however, are not measures of financial performance under accounting principles generally accepted in the United States of America (“GAAP”) and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operations as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:

•

“organic revenue” and “organic orders” defined as revenue and orders, respectively, excluding the impact of foreign currency fluctuations, intercompany transactions and contributions from acquisitions and divestitures. Divestitures include sales of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency fluctuations assumes no change in exchange rates from the prior period.

•

“constant currency” defined as financial results adjusted for currency by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

•

“adjusted net income” and “adjusted earnings per share” defined as net income and earnings per share, respectively, adjusted to exclude non-recurring separation costs associated with the Spin-off and tax-related special items. A reconciliation of adjusted net income is provided below.


	Three Months Ended June 30,					Six Months Ended June 30,
(In millions, except for per share data)	2012			2011		2012			2011
Net income	$	89		$	72	$	152		$	150
Separation costs, net of tax		4			27		8			29
Tax-related special items		(1	)		4		(1	)		4

Adjusted net income	$	92		$	103	$	159		$	183


Weighted average number of shares - Diluted		186.2			184.6		186.1			184.6
Adjusted earnings per share (a)	$	0.49		$	0.56	$	0.85		$	0.99

(a)	Subsequent to the Spin-off on October 31, 2011, we had 184.6 million shares of common stock outstanding and this share amount is being utilized to calculate diluted earnings per share for all periods prior to October 31, 2011 presented.

•

“operating expenses excluding separation costs” defined as operating expenses, adjusted to exclude non-recurring costs incurred in connection with the separation.

•

“adjusted segment operating income” defined as segment operating income, adjusted to exclude non-recurring costs incurred in connection with the separation and “adjusted segment operating margin” defined as adjusted segment operating income divided by total segment revenue.

•

“free cash flow” defined as net cash provided by operating activities less capital expenditures as well as adjustments for other significant items that impact current results that management believes are not related to our ongoing operations and performance. Our definition of free cash flow does not consider certain non-discretionary cash payments, such as debt. The following table provides a reconciliation of free cash flow.


	Six Months Ended June 30,
(In millions)	2012			2011
Net cash provided by operating activities	$	125		$	161
Capital expenditures		(57	)		(53	)
Separation cash payments (a)		18			26

Free cash flow	$	86		$	134

(a)	Includes separation costs allocated by ITT in 2011 that have been treated as though they were settled in cash and capital expenditures associated with the spin of $2 million and $5 million for 2012 and 2011, respectively.

Results of Operations


(In millions)	Three Months Ended June 30,									Six Months Ended June 30,
(In millions)	2012			2011			Change			2012			2011			Change
Revenue	$	966		$	971			(0.5	)%	$	1,891		$	1,861			1.6	%
Gross Profit		383			379			1.1	%		746			716			4.2	%
Gross Margin		39.6	%		39.0	%		60	bp		39.5	%		38.5	%		100	bp
Operating expenses excluding separation costs		248			245			1.2	%		507			479			5.8	%
Expense to revenue ratio		25.7	%		25.2	%		50	bp		26.8	%		25.7	%		110	bp
Separation costs		6			18			(66.7	)%		11			21			(47.6	)%
Total operating expenses		254			263			(3.4	)%		518			500			3.6	%
Operating Income		129			116			11.2	%		228			216			5.6	%
Operating Margin		13.4	%		11.9	%		150	bp		12.1	%		11.6	%		50	bp
Interest and other non-operating expense (income), net		14			1						29			—
Income tax expense		26			43			(39.5	)%		47			66			(28.8	)%
Tax rate		23.3	%		37.4	%		(1,410	)bp		23.9	%		30.6	%		(670	)bp
Net Income	$	89		$	72			23.6	%	$	152		$	150			1.3	%

Revenue

Revenue generated during the three and six months ended June 30, 2012 was $966 million and $1,891 million, respectively, reflecting a decrease of $5 million or 0.5% and an increase of $30 million or 1.6% as compared to the same respective prior year periods. On a constant currency basis, revenue grew 4.5% and 5.0% for the three and six months ended June 30, 2012, respectively. The following table illustrates the impact from organic growth, recent acquisitions, and fluctuations in foreign currency, in relation to revenue during the three and six months ended June 30, 2012.


	Three Months Ended June 30,						Six Months Ended June 30,
(In millions)	Change			% Change			Change			% Change
2011 Revenue	$	971					$	1,861
Organic growth		12			1.2	%		27			1.5	%
Acquisitions		32			3.3	%		66			3.5	%

Constant Currency		44			4.5	%		93			5.0	%
Foreign currency translation(a)		(49	)		(5.0	)%		(63	)		(3.4	)%

Total change in revenue		(5	)		(0.5	)%		30			1.6	%

2012 Revenue	$	966					$	1,891

(a)	Foreign currency impact primarily due to fluctuations in the value of the Euro against the U.S. Dollar.

The following table summarizes revenue by segment:


	Three Months Ended June 30,												Six Months Ended June 30,
(In millions)	2012			2011			As Reported Change			Constant Currency Change			2012			2011			As Reported Change			Constant Currency Change
Water Infrastructure	$	609		$	602			1.2	%		7.3	%	$	1,193		$	1,153			3.5	%		7.5	%
Applied Water		373			385			(3.1	)%		0.3	%		728			740			(1.6	)%		0.8	%
Eliminations		(16	)		(16	)								(30	)		(32	)

Total	$	966		$	971			(0.5	)%		4.5	%	$	1,891		$	1,861			1.6	%		5.0	%

Water Infrastructure

Water Infrastructure revenue increased $7 million, or 1.2% for the second quarter of 2012 (7.3% growth at constant currency) and $40 million, or 3.5% for the six months ended June 30, 2012 (7.5% growth at constant currency) compared to the respective 2011 periods. The growth on a constant currency basis was driven by organic revenue growth and benefits from acquisitions.

Organic revenue growth of $11 million or 1.8% during the quarter was primarily attributable to transport performance, particularly in the public utility sector of emerging markets, as well as dewatering applications within industrial markets. Revenues from treatment decreased due to weaker sales in developed markets mainly due to challenging economic conditions within Europe and timing of projects, but were partially offset by strength in the Middle East, Africa, and Latin America. The test business also declined primarily due to weakness in Europe.

Incremental revenue from the YSI acquisition in September 2011 contributed $32 million and $66 million for the three and six months ended June 30, 2012, respectively.

Applied Water

Applied Water revenue decreased $12 million, or 3.1% for the second quarter of 2012 (0.3% growth at constant currency) and $12 million, or 1.6% for the six months ended June 30, 2012 (0.8% growth at constant currency) compared to the respective 2011 periods. The revenue growth on a constant currency basis was due to modest organic revenue growth.

Organic revenue growth was flat for the second quarter and increased $5 million, or 0.7% for the six months ended June 30, 2012 as compared to the prior year as price increases more than offset volume declines, largely driven by uncertainties with the economy in Europe. On an application basis, industrial water increased overall due to strength in the U.S. markets, partially offset by European declines. This growth was largely offset by declines in building services, due to weakness in Europe, Middle East, Africa, and Asia, and declines in irrigation as growth in the Americas was more than offset by reductions primarily in Europe.

Orders / Backlog

Orders received during the second quarter of 2012 decreased by $28 million, or 2.8% over the second quarter of the prior year to $970 million (2.3% growth at constant currency), including a benefit of $30 million from acquisitions. Orders received during the six months of 2012 decreased by $2 million from the respective prior year period, or 0.1% to $1,974 million (3.4% growth at constant currency), including a benefit of $67 million from acquisitions. Organic order growth declined 0.7% for the second quarter and was flat for the six months ended June 30, 2012.

The Water Infrastructure segment order growth decreased $15 million, or 2.4% to $617 million (4.0% growth at constant currency), for the quarter ended June 30, 2012 as compared to the respective prior year quarter, including $30 million from acquisitions. Organic order volume declined 0.8% principally due to slowed or delayed projects from the uncertainty in Europe, particularly within the treatment market. Orders received during the six months of 2012 increased $11 million, or 0.9% to $1,255 million (5.1% growth at constant currency) as compared to the respective prior year period, including $67 million from acquisitions. The decrease in the year-to-date organic orders of 0.2% is attributable to the strong first quarter orders particularly within the industrial dewatering market and flood mitigation in Australia more than offset by the second quarter declines.

Applied Water order growth decreased $13 million and $12 million, or 3.4% (flat at constant currency) and 1.6% (0.8% growth at constant currency) for the three and six month periods ending June 30, 2012, respectively. Organic order volume was relatively flat for both the three and six month periods reflecting the similar market dynamics impacting revenue.

Delivery schedules vary from customer to customer based upon their requirements. Typically, large projects require longer lead production cycles and delays can occur from time to time. Total backlog was $720 million at June 30, 2012, a decrease of $38 million or 5% as compared to $758 million at June 30, 2011 and an increase of $69 million or 10.6% as compared to $651 million at December 31, 2011. We anticipate that approximately 80% of the backlog at June 30, 2012 will be recognized as revenue in the remainder of 2012.

Gross Margin

Gross margin as a percentage of revenue increased to 39.6% for the quarter ended and 39.5% for the six months ended June 30, 2012 compared to 39.0% and 38.5%, respectively, for the comparable periods of 2011. The increase is primarily attributable to benefits from price realization initiatives, factory productivity, favorable material costs, and incremental revenue as a result of the acquisition of YSI. These benefits were offset, in part, by higher labor costs and general inflation impacts.

Operating Expenses excluding Separation Costs

The following table presents operating expenses for the three and six month periods ended June 30, 2012 and 2011:


	Three Months Ended June 30,									Six Months Ended June 30,
(In millions)	2012			2011			Change			2012			2011			Change
Selling, General and Administrative (SG&A)	$	220		$	219			0.4	%	$	451		$	429			5.1	%
SG&A as a % of revenue		22.8	%		22.6	%		20	bp		23.8	%		23.1	%		70	bp
Research and Development (R&D)	$	28		$	26			7.7	%	$	56		$	50			12	%
R&D as a % of revenue		2.9	%		2.7	%		20	bp		3.0	%		2.7	%		30	bp
Operating expenses excluding separation costs	$	248		$	245			1.2	%	$	507		$	479			5.8	%
Expense to revenue		25.7	%		25.2	%		50	bp		26.8	%		25.7	%		110	bp

Selling, General and Administrative Expenses

SG&A increased by $1 million to $220 million or 22.8% of revenue in the second quarter of 2012, as compared to $219 million or 22.6% of revenue in the second quarter of 2011; and increased by $22 million to $451 million or 23.8% of revenue in the six months ended June 30, 2012, as compared to

$429 million or 23.1% of revenue in 2011. The increase in SG&A expenses as a percentage of revenue is primarily due to additional expenses incurred as a standalone company, which were partially offset by cost saving initiatives instituted by the Company.

Research and Development Expenses

R&D spending increased $2 million to $28 million or 2.9% of revenue in the second quarter of 2012 as compared to $26 million or 2.7% of revenue in the comparable period of 2011; and increased by $6 million to $56 million or 3.0% of revenue for the six months ended June 30, 2012 as compared to $50 million, or 2.7% of revenue in 2011. The increases to R&D are reflective of incremental expenses from the YSI acquisition, as well as costs associated with the launching of several new products planned for the third and fourth quarters of 2012.

Separation Costs

We incurred non-recurring separation costs as a result of the spin-off from ITT as follows:


	Three Months Ended June 30,					Six Months Ended June 30,
(in millions)	2012			2011		2012			2011
Rebranding and marketing costs	$	2		$	1	$	4		$	1
Employee retention and hiring costs		1			3		1			4
Information and technology costs		1			7		1			7
Advisory fees and other		2			7		5			9

Total separation costs in operating income		6			18		11			21
Income tax expense (benefit)		(2	)		9		(3	)		8

Total separation costs, net of tax	$	4		$	27	$	8		$	29

Our current estimate of the pre-tax cash impact of the remaining activities associated with the Spin-off ranges from approximately $4 million to $9 million.

Operating Income

We generated operating income of $129 million during the second quarter of 2012, a $13 million increase compared to $116 million in the second quarter of 2011, and $228 million in the six months ended June 30, 2012, an increase of $12 million compared to $216 million in 2011. These results include non-recurring separation costs of $6 million and $11 million for the three and six months ended June 30, 2012, respectively, and $18 million and $21 million for the same comparable prior year periods. The three and six months ended June 30, 2012 also include increased expenses incurred as a standalone company. The following table illustrates operating income results for our business segments.


	Three Months Ended June 30,									Six Months Ended June 30,
(In millions)	2012			2011			Change			2012			2011			Change
Water Infrastructure	$	93		$	94			(1.1	)%	$	167		$	158			5.7	%
Applied Water		52			50			4.0	%		92			96			(4.2	)%

Segment operating income		145			144			0.7	%		259			254			2.0	%
Corporate and other		(16	)		(28	)		(42.9	)%		(31	)		(38	)		(18.4	)%

Total operating income	$	129		$	116			11.2	%	$	228		$	216			5.6	%

Operating margin		*13.4*	%		11.9	%		150	bp		*12.1*	%		11.6	%		50	bp

The table below provides a reconciliation from segment operating income to adjusted operating income, and a calculation of the corresponding adjusted operating margin.


	Three Months Ended June 30,									Six Months Ended June 30,
(In millions)	2012			2011			Change			2012			2011			Change
Water Infrastructure
Operating income	$	93		$	94			(1.1	)%	$	167		$	158			5.7	%
Separation costs		1			2						3			2

Adjusted operating income	$	94		$	96			(2.1	)%	$	170		$	160			6.3	%
Adjusted operating margin		*15.4*	%		15.9	%		(50	)bp		*14.2*	%		13.9	%		30	bp
Applied Water
Operating income	$	52		$	50			4.0	%	$	92		$	96			(4.2	)%
Separation costs		—			—						1			—

Adjusted operating income	$	52		$	50			4.0	%	$	93		$	96			(3.1	)%
Adjusted operating margin		*13.9*	%		13.0	%		90	bp		*12.8*	%		13.0	%		(20	)bp
Total Xylem
Operating income	$	129		$	116			11.2	%	$	228		$	216			5.6	%
Separation costs		6			18						11			21

Adjusted operating income	$	*135*		$	134			0.7	%	$	*239*		$	237			0.8	%
Adjusted operating margin		*14.0*	%		13.8	%		20	bp		*12.6*	%		12.7	%		(10	)bp

Water Infrastructure

Operating income for our Water Infrastructure segment decreased $1 million or 1.1% ($2 million or 2.1% excluding separation costs) for the quarter ended June 30, 2012 compared with the respective prior year quarter as the decline in revenue driven by the weakness in Europe and lower overall dewatering mix was partially offset by the measures taken by the Company to reduce operating costs. Operating income increased for the segment by $9 million or 5.7% ($10 million or 6.3% excluding separation costs) for the six months ended June 30, 2012, compared with the same six month period for the prior year, as incremental operating income from the YSI acquisition of $16 million and strength in the emerging market public utility and industrial sectors were partially offset by unfavorable foreign exchange translation adjustments and increased spending on research and development as well as unfavorable impacts of inflation on labor.

Applied Water

Operating income for our Applied Water segment increased $2 million or 4.0% for the quarter ended June 30, 2012 compared with the respective prior year quarter as the operating cost reductions put in place by the Company were partially offset by unfavorable foreign exchange translation adjustments. The increase in operating income for the second quarter was also driven by a reduction of a contract loss accrual previously recorded by the Company. Operating income decreased $4 million or 4.2% ($3 million or 3.1% excluding separation costs) for the six months ended June 30, 2012, compared with the same six month period for the prior year as the decline in revenue driven by the warm winter and the challenging economic conditions in Europe, was partially offset by the operating cost reductions, reduction of a contract loss accrual and price realizations.

Interest Expense

Interest expense was $13 million and $27 million for the three and six months ended June, 30 2012 primarily related to the interest from the issuance of $1.2 billion aggregate principal amount of senior notes issued in September 2011. Refer to Note 11, “Credit Facilities and Long-Term Debt,” for further details.

Income Tax Expense

On June 8, 2012, the Swedish government submitted to the Council on Legislation an exposure draft on proposed tax legislation that, if enacted, could adversely impact the Company’s effective tax rate. The Company is currently assessing potential opportunities to mitigate this potential impact.

Liquidity and Capital Resources

The following table summarizes our sources and uses of cash.


	Six Months Ended June 30,
(In millions)	2012			2011			Change
Operating activities	$	125		$	161		$	(36	)
Investing activities		(53	)		(48	)		(5	)
Financing activities		(31	)		(112	)		81
Foreign exchange		(1	)		6			(7	)

Total	$	40		$	7		$	33

Sources and Uses of Liquidity

Operating Activities

During the first six months of 2012, net cash provided by operating activities declined by $36 million as compared to the first six months of 2011. The year-over-year decrease is primarily driven by interest payments on debt of $26 million in 2012 as well as higher tax payments of $36 million, partially offset by an increase in receivable collections.

Investing Activities

Cash used in investing activities was $53 million for the six months of 2012 as compared to $48 million in the comparable period of 2011. Capital expenditures in the first six months of 2012 were $57 million as compared to $53 million in the first six months of 2011. The increase in capital expenditures was driven by $2 million of capital expenditures related to separation activities.

Financing Activities

Cash used in financing activities was $31 million for the six months of 2012 as compared to $112 million in the first six months of 2011. Cash financing during the first six months of 2012 was driven by dividend payments of $39 million, partially offset by $16 million of proceeds from the exercise of stock options. For 2011, we had $112 million net transfer to our former parent, ITT. In general, the components of net transfers include: (i) cash transfers from the Company to parent, (ii) cash investments from our parent used to fund operations, capital expenditures and acquisitions, (iii) charges (benefits) for income taxes, and (iv) allocations of the parent company’s corporate expenses described in this quarterly report.

Funding and Liquidity Strategy

Prior to the Spin-off, the majority of our operations participated in U.S. and international cash management and funding arrangements managed by ITT where cash was swept from our balance sheet daily, and cash to meet our operating and investing needs was provided as needed from ITT.

As a result of the separation, our capital structure and sources of liquidity changed significantly. We no longer participate in cash management and funding arrangements with ITT. Instead, our ability to fund our capital needs depends on our ongoing ability to generate cash from operations, and access to the bank and capital markets.

Historically, we have generated operating cash flow sufficient to fund our primary cash needs centered on operating activities, working capital, capital expenditures, and strategic investments. If our cash flows from operations are less than we expect, we may need to incur debt or issue equity. From time to time, we may need to access the long-term and short-term capital markets to obtain financing. Our access to, and the availability of, financing on acceptable terms and conditions in the future will be impacted by many factors, including: (i) our credit ratings or absence of a credit rating, (ii) the liquidity of the overall capital markets, and (iii) the current state of the economy. There can be no assurance that we will continue to have access to the capital markets on terms acceptable to us. We cannot assure that such financing will be available to us on acceptable terms or that such financing will be available at all.

We anticipate that our present sources of funds, including funds from operations and additional borrowings, will provide us with sufficient liquidity and capital resources to meet our liquidity and capital needs in both the United States and outside of the United States over the next twelve months.

Senior Notes

On September 20, 2011, we issued 3.550% Senior Notes of $600 million aggregate principal amount due September 2016 (the “2016 Notes”) and 4.875% Senior Notes of $600 million aggregate principal amount due October 2021 (the “2021 Notes” and together with the 2016 Notes, the “Senior Notes”). The issuance resulted in gross proceeds of $1.2 billion, offset by $9 million in debt issuance costs which were capitalized and are included within other assets. The Senior Notes include covenants which restrict our ability, subject to exceptions, to incur debt secured by liens and engage in sale and lease-back transactions, as well as provide for customary events of default (subject, in certain cases, to receipt of notice of default and/or customary grace and cure periods), including but not limited to, (i) failure to pay interest for 30 days, (ii) failure to pay principal when due, (iii) failure to perform any other covenant for 90 days after receipt of notice from the trustee or from holders of 25% of the outstanding principal amount and (iv) certain events of bankruptcy, insolvency or reorganization. We may redeem the Senior Notes, as applicable, in whole or in part, at any time at a redemption price

equal to the principal amount of the Senior Notes to be redeemed, plus a make-whole premium. As of June 30, 2012, we were in compliance with all covenants. If a change of control of Xylem triggering event occurs, we will be required to make an offer to purchase the Senior Notes at a price equal to 101% of their principal amount plus accrued and unpaid interest to the date of repurchase.

Credit Facility

Non-U.S. Operations

For the six months ended June 30, 2012 and 2011, we generated approximately 63% and 64%, respectively, of our revenue from non-U.S. operations. As we continue to grow our operations in the emerging markets and elsewhere outside of the United States, we expect to continue to generate significant revenue from non-U.S. operations and we expect our cash will be predominately held by our foreign subsidiaries. We expect to manage our worldwide cash requirements considering available funds among the many subsidiaries through which we conduct business and the cost

effectiveness with which those funds can be accessed. We may transfer cash from certain international subsidiaries to the U.S. and other international subsidiaries when it is cost effective to do so. Our intent is to indefinitely reinvest all but $100 million of these funds outside of the United States. However, we continually review our domestic and foreign cash profile, expected future cash generation and investment opportunities which support our current designation of these funds as being indefinitely reinvested and reassess whether there is a demonstrated need to repatriate funds held internationally to support our U.S. operations. If, as a result of our review, it is determined that all or a portion of the funds may be needed for our operations in the United States, we would be required to accrue U.S. taxes related to future tax payments associated with the repatriation of these funds. As of June 30, 2012, our foreign subsidiaries were holding $248 million in cash or marketable securities.

Contractual Obligations

In our 2011 Annual Report, we presented a table that summarized our contractual commitments as of December 31, 2011, including operating lease obligations.

Subsequent to the issuance of our annual financial statements, we identified that we had incorrectly aggregated data from certain of our foreign subsidiaries related to our future minimum rental payments. As a result, we have adjusted certain amounts below to reflect the corrected future minimum rental payments.

The following table summarizes our operating lease obligations as of December 31, 2011. There have been no material changes to our minimum rental obligations subsequent to December 31, 2011.


(in millions)	2012		2013-2014		2015-2016		Thereafter		Total
Operating lease obligations	$	54	$	71	$	39	$	36	$	200

Critical Accounting Estimates

Our discussion and analysis of our results of operations and capital resources are based on our condensed consolidated and combined financial statements, which have been prepared in conformity with GAAP. The preparation of these condensed consolidated and combined financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities. We believe the most complex and sensitive judgments, because of their significance to the condensed consolidated and combined financial statements, result primarily from the need to make estimates about the effects of matters that are inherently uncertain. Management’s Discussion and Analysis of Financial Condition and Results of Operations in the 2011 Annual Report describes the critical accounting estimates used in preparation of the condensed consolidated and combined financial statements. Actual results in these areas could differ from management’s estimates. There have been no significant changes in the information concerning our critical accounting estimates as stated in our 2011 Annual Report.

New Accounting Pronouncements

See Note 2, Recent Accounting Pronouncements, in the Notes to the condensed combined financial statements for a complete discussion of recent accounting pronouncements. There were no new pronouncements that we expect to have a material impact on our financial condition, results of operations or cash flows in future periods.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There has been no material change in the information concerning market risk as stated in our 2011 Annual Report.

ITEM 4.

CONTROLS AND PROCEDURES

Our management, with the Chief Executive Officer and Chief Financial Officer of the Company, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this quarterly report. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Based on such evaluation, such officers have concluded that, as of the end of the period covered by this Report the Company’s disclosure controls and procedures are effective at the reasonable assurance level.

There have been no changes in our internal control over financial reporting during the fiscal quarter covered by this quarterly report that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.

PART II

ITEM 1. LEGAL PROCEEDINGS

From time to time, we are involved in legal proceedings that are incidental to the operation of our businesses. Some of these proceedings seek remedies relating to environmental matters, intellectual property matters, personal injury claims, employment and pension matters, government contract issues and commercial or contractual disputes, sometimes related to acquisitions or divestitures. See Note 14 “Commitments and Contingencies” to the condensed consolidated and combined financial statements for further information and any updates.

ITEM 1A. RISK FACTORS

There have been no material changes from the risk factors previously disclosed in our 2011 Annual Report.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURE

None.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

See Exhibit Index.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.


		XYLEM INC.
		(Registrant)

		/s/ John P. Connolly
		John P. Connolly
		Vice President and Chief Accounting Officer
		(Principal Accounting Officer)

August 2, 2012

XYLEM INC.

EXHIBIT INDEX


Exhibit Number		Description	Location

	(3.1)	Amended and Restated Articles of Incorporation of Xylem Inc.	Incorporated by reference to Exhibit 3.1 of Xylem Inc.’s Form 8-K Current Report filed on October 13, 2011 (CIK No. 1524472, File No. 1-35229).

	(3.2)	By-laws of Xylem Inc.	Incorporated by reference to Exhibit 3.2 of Xylem Inc.’s Form 8-K Current Report filed on October 13, 2011 (CIK No. 1524472, File No. 1-35229).

	(4.1)	Indenture, dated as of September 20, 2011, between Xylem Inc., ITT Corporation, as initial guarantor, and Union Bank, N.A., as trustee	Incorporated by reference to Exhibit 4.2 of ITT Corporation’s Form 8-K Current Report filed on September 21, 2011 (CIK No. 216228, File No. 1-5672).

	(4.2)	Form of Xylem Inc. 3.550% Senior Notes due 2016	Incorporated by reference to Exhibit 4.5 of ITT Corporation’s Form 8-K Current Report filed on September 21, 2011 (CIK No. 216228, File No. 1-5672).

	(4.3)	Form of Xylem Inc. 4.875% Senior Notes due 2021	Incorporated by reference to Exhibit 4.6 of ITT Corporation’s Form 8-K Current Report filed on September 21, 2011 (CIK No. 216228, File No. 1-5672).

	(4.4)	Registration Rights Agreement, dated as of September 20, 2011, between Xylem Inc., ITT Corporation and J.P. Morgan Securities LLC, RBS Securities Inc. and Wells Fargo Securities, LLC as representatives of the Initial Purchasers	Incorporated by reference to Exhibit 4.8 of ITT Corporation’s Form 8-K Current Report filed on September 21, 2011 (CIK No. 216228, File No. 1-5672).

	(11)	Statement re computation of per share earnings	Information required to be presented in Exhibit 11 is provided under “Earnings Per Share” in Note 5 to the Condensed Consolidated and Combined Financial Statements in Part I, Item 1 “Condensed Consolidated and Combined Financial Statements” of this Report in accordance with the provisions of Financial Accounting Standards Board Accounting Standards Codification 260, Earnings Per Share.

	(31.1)	Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	Filed herewith.


Exhibit Number		Description	Location

	(31.2)	Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	Filed herewith.

	(32.1)	Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	This Exhibit is intended to be furnished in accordance with Regulation S-K Item 601(b) (32) (ii) and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference.

	(32.2)	Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	This Exhibit is intended to be furnished in accordance with Regulation S-K Item 601(b) (32) (ii) and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference.

	(101)	The following materials from Xylem Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2012, formatted in XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated and Combined Income Statements, (ii) Condensed Consolidated and Combined Statements of Comprehensive Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated and Combined Statements of Cash Flows and (v) Notes to Condensed Consolidated and Combined Financial Statements	Submitted electronically with this Report.